SCHEMBL659986

SCHEMBL659986

O=C(CN1C=CCC(c2cc(-c3ccc(Br)cc3)no2)=C1)c1cccs1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.35
RAB9A P51151 5/20 0.35
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
PTPN1 P18031 1/20 0.35
ALDH1A1 P00352 5/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2B Q13224 1/20 0.34
TP53 P04637 2/20 0.33
ABL1 P00519 1/20 0.33
BCR P11274 1/20 0.33
MAPK1 P28482 1/20 0.33
PPARA Q07869 1/20 0.33
CXCR1 P25024 1/20 0.33
ACKR3 P25106 1/20 0.33
THRB P10828 1/20 0.33
HTT P42858 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL661206 0.87 HSD17B1 (0.42) NPC1RAB9AKMT2AALDH1A1SMN1; SMN2
SCHEMBL287429 0.77 NPSR1 (0.36) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL297726 0.74 MAPT (0.38) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL298661 0.73 KMT2A (0.37) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL298118 0.71 NPC1 (0.44) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL7808911 0.70 ALDH1A1 (0.48) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL660093 0.69 ALDH1A1 (0.44) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL661245 0.68 ALDH1A1 (0.43) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL287279 0.68 GRM5 (0.39) NPC1RAB9APOLBKMT2AALDH1A1
SCHEMBL661687 0.67 ERCC5 (0.43) NPC1RAB9AMEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US claimed
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT NPC1 1176/4885RAB9A 2179/4885MEN1 1455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.